Data-Driven Patterns in Protective Effects of Ibuprofen and Ketorolac on Hospitalized Covid-19 Patients

The impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on patients with Covid-19 has been unclear. A major reason for this uncertainty is the confounding between treatments, patient comorbidities, and illness severity. Here, we perform an observational analysis of over 3000 patients hospitalized for Covid-19 in a New York hospital system to identify the relationship between in-patient treatment with Ibuprofen or Ketorolac and mortality. Our analysis finds evidence consistent with a protective effect for Ibuprofen and Ketorolac, with evidence stronger for a protective effect of Ketorolac than for a protective effect of Ibuprofen.

Sleepy Doctors: Work Hours and the Accreditation Council for Graduate Medical

On March 5, 1984, Bennington College freshman Libby Zion died at New York Hospital. She had been admitted the night before with vague symptoms and strange jerking motions. After consulting with her family physician, the residents on call gave her intravenous solutions for possible dehydration and prescribed meperidine to control her jerking motions. They then left to take care of other patients. Luise Weinstein, the first-year resident, was responsible for 40 other patients. No sleep for her.